Published in Br J Cancer on April 08, 2008
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst (2009) 3.77
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol (2011) 1.65
Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years. Br J Cancer (2013) 1.33
Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis (2013) 1.21
Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer (2010) 1.09
Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer (2013) 1.08
Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. Br J Cancer (2009) 1.08
Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev (2010) 1.08
Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer (2012) 1.07
Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol (2009) 1.03
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens. J Mol Diagn (2011) 0.98
The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol (2009) 0.95
Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer (2008) 0.92
Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women. Obstet Gynecol Sci (2013) 0.90
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study. J Clin Microbiol (2013) 0.89
High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect (2013) 0.87
Human papillomavirus types distribution in organised cervical cancer screening in France. PLoS One (2013) 0.85
Cervical human papillomavirus infection in a sample of Hispanic women living in Puerto Rico: comparison with cervical cytology reports. P R Health Sci J (2013) 0.85
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV. J Immunol Res (2015) 0.84
Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infect Dis (2010) 0.82
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study. BMC Cancer (2016) 0.81
Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65. Gynecol Oncol (2014) 0.79
Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia. Cochrane Database Syst Rev (2010) 0.78
HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells. Sci Rep (2015) 0.76
Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia. PLoS One (2017) 0.75
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Classification of papillomaviruses. Virology (2004) 14.16
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol (1995) 10.07
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Determinants of genital human papillomavirus detection in a US population. J Infect Dis (2001) 3.21
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis (2006) 2.21
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol (2006) 1.96
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol (2006) 1.24
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med (1991) 12.89
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Cohort study analysis with a FORTRAN computer program. Int J Epidemiol (1986) 6.66
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Autism screening questionnaire: diagnostic validity. Br J Psychiatry (1999) 6.61
Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. BMJ (2000) 6.14
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol (2001) 6.05
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (1994) 5.76
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Ciprofloxacin resistance in gonococci. Lancet (1990) 4.90
Systematic gain-of-function genetics in Drosophila. Development (1998) 4.71
A case-control family history study of autism. J Child Psychol Psychiatry (1994) 4.66
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet (1997) 4.38
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev (2005) 3.97
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
The cornea is not a piece of plastic. J Refract Surg (2000) 3.72
Micro-organisms in the Healthy Nose. Med Chir Trans (1895) 3.72
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet (1995) 3.71
Management of women with mild and moderate cervical dyskaryosis. BMJ (1994) 3.65
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer (1982) 3.61
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58
Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax (1981) 3.49
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell (2001) 3.34
Survey of medical training in cytopathology carried out by the journal Cytopathology. Cytopathology (2010) 3.32
A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1995) 3.17
Environment. Can we defy nature's end? Science (2001) 3.14
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03
Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet (1995) 2.94
Disparities in cancer diagnosis and survival. Cancer (2001) 2.81
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer (2005) 2.81
Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74
Measuring performance to drive improvement: development of a clinical indicator set for general medicine. Intern Med J (2009) 2.66
Epidural abscess complicating insertion of epidural catheters. Br J Anaesth (2002) 2.65
How to reduce the stress of general dental practice: the need for research into the effectiveness of multifaceted interventions. Br Dent J (2006) 2.64
Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet (1980) 2.60
Tracing the first stars with fluctuations of the cosmic infrared background. Nature (2005) 2.60
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
Association of hyperglycemia with increased mortality after severe burn injury. J Trauma (2001) 2.55
Psychiatric morbidity associated with screening for breast cancer. Br J Cancer (1989) 2.53
UK National Guidelines on the Management of Syphilis 2008. Int J STD AIDS (2008) 2.53
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut (2002) 2.50
Inhaling habits among smokers of different types of cigarette. Thorax (1980) 2.50
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet (2001) 2.40
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Childhood lead poisoning in Massachusetts communities: its association with sociodemographic and housing characteristics. Am J Public Health (1995) 2.39
Viral hepatitis. A staff hazard in dialysis units. Lancet (1967) 2.38
A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry (1996) 2.38
Anopheles gambiae pilot gene discovery project: identification of mosquito innate immunity genes from expressed sequence tags generated from immune-competent cell lines. Proc Natl Acad Sci U S A (2000) 2.38
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Variable expression of the autism broader phenotype: findings from extended pedigrees. J Child Psychol Psychiatry (2000) 2.33
Retinal thickness measurements from optical coherence tomography using a Markov boundary model. IEEE Trans Med Imaging (2001) 2.29
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25
Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans (1996) 2.23
Price and consumption of cigarettes: a case for intervention? Br J Prev Soc Med (1974) 2.22
Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet (2000) 2.19
The growth of cells in serum-free hormone-supplemented media. Methods Enzymol (1979) 2.18
Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer (2009) 2.18
Multidimensional Treatment Foster Care for Adolescents in English care: randomised trial and observational cohort evaluation. Br J Psychiatry (2013) 2.16
Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry (1986) 2.14
Carboxyhaemoglobin levels and inhaling habits in cigarette smokers. Thorax (1978) 2.13
Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07
Nursing practice. Triage on trial. Nurs Times (1988) 2.06
Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol (1993) 2.04
Redefining the Guillain-Barré spectrum in children: neuroimaging findings of cranial nerve involvement. AJNR Am J Neuroradiol (2011) 2.03
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Interventions for treating plantar heel pain. Cochrane Database Syst Rev (2003) 2.03
Survey of general practitioners' treatment of the discharging ear. Br Med J (Clin Res Ed) (1988) 2.02
The hygiene standard for chrysotile asbestos. Lancet (1978) 2.02
Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ (1996) 2.00
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99
Use of carboxyhaemoglobin levels to predict the development of diseases associated with cigarette smoking. Thorax (1975) 1.93
Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell (1997) 1.93
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 5. General discussion and conclusions. Cleft Palate Craniofac J (1992) 1.92
National study of colorectal cancer genetics. Br J Cancer (2007) 1.92
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol (2001) 1.91
The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Vox Sang (2010) 1.91
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer (2010) 1.89